Lower than expected hepatitis B virus infection prevalence among first generation Koreans in the U.S.: results of HBV screening in the Southern California Inland Empire by Natali Navarro et al.
RESEARCH ARTICLE Open Access
Lower than expected hepatitis B virus infection
prevalence among first generation Koreans in the
U.S.: results of HBV screening in the Southern
California Inland Empire
Natali Navarro1, Nelson Lim2, Jiah Kim2, Elliot Joo2, Kendrick Che2, Bruce Allen Runyon2
and Michel Henry Mendler2*
Abstract
Background: Hepatitis B virus (HBV) infection is prevalent in Asian immigrants in the USA. California’s Inland Empire
region has a population of approximately four million, including an estimated 19,000 first generation Koreans. Our aim
was to screen these adult individuals to establish HBV serological diagnoses, educate, and establish linkage to care.
Methods: A community-based program was conducted in Korean churches from 11/2009 to 2/2010. Subjects were
asked to complete a HBV background related questionnaire, provided with HBV education, and tested for serum HBsAg,
HBsAb and HBcAb. HBsAg positive subjects were tested for HBV quantitative DNA, HBeAg and HBeAb, counseled and
directed to healthcare providers. Subjects unexposed to HBV were invited to attend a HBV vaccination clinic.
Results: A total of 973 first generation Koreans were screened, aged 52.3y (18-93y), M/F: 384/589. Most (75%) had a
higher than high school education and were from Seoul (62.2%). By questionnaire, 24.7% stated they had been
vaccinated against HBV. The serological diagnoses were: HBV infected (3.0%), immune due to natural infection (35.7%),
susceptible (20.1%), immune due to vaccination (40.3%), and other (0.9%). Men had a higher infection prevalence
(4.9% vs. 1.7%, p = 0.004) and a lower vaccination rate (34.6% vs. 44.0%, p = 0.004) compared to women. Self-reports of
immunization status were incorrect for 35.1% of subjects.
Conclusions: This large screening study in first generation Koreans in Southern California demonstrates: 1) a lower than
expected HBV prevalence (3%), 2) a continued need for vaccination, and 3) a need for screening despite a reported
history of vaccination.
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Background
Hepatitis B is caused by the hepatitis B virus (HBV),
which is transmitted through exposure to infectious
body fluids. Most HBV carriers remain contagious for
the rest of their lives. Chronic infection can lead to cir-
rhosis and liver cancer. An estimated 350 million people
are diagnosed with hepatitis B worldwide [1]. Of those
with chronic HBV infection 20% die from liver related
disease complications.
In the U.S. the chronic HBV infection prevalence, de-
fined by a positive hepatitis B surface antigen (HBsAg),
is estimated to be 0.3-0.5% [2]. This low rate is partly at-
tributed to HBV vaccination and prevention strategies
established nationally since 1991, ahead of the World
Health Organization’s (WHO) recommendations. The
WHO’s resolution to include HBV immunization in
childhood vaccination programs worldwide began in
1992 [3]. By WHO reports, childhood HBV vaccination
policies were in place in 93% of its member states by
2012 [4]. Yet, HBV infection persists as a global health
challenge with the prevalence remaining high, especially
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in Asia where most infections are acquired perinatally or
during early childhood.
South Korea is currently classified by the Centers for
Disease Control and Prevention (CDC) as an endemic
area (≥8%) for HBV infection. Prior to the inclusion of the
HBV vaccine in the Korean mandatory immunization pro-
gram in 1995, the prevalence of HBV was estimated at
8.2% [5]. However, following WHO guidelines, the im-
plementation of vaccination policies in South Korea
have resulted in a decrease of HBV prevalence. In 1998
the National Health and Nutrition Survey reported
HBV infection in South Korea to be 4.6% [6]. Data from
the same survey in 2007 indicated a decline to 3.7%
[7,8]. Similarly significant decreases in prevalence have
been reported across Asia as a result of hepatitis B vac-
cination policies [9-11].
In the U.S. the CDC estimates two-thirds of those
chronically infected with HBV are foreign-born and
about half are of Asian descent [12]. Accordingly,
current AASLD guidelines recommend HBV screening
for Asians, yet recent survey data [13-15] shows among
insured Asian-American patients only about half are
tested. These studies also show healthcare providers do
not perceive patients’ racial background or country of
origin with high endemicity as risk factors for HBV,
and that among primary care providers serving large
American Asian communities only two thirds under-
stand the serological tests required to identify infec-
tion. HBV prevalence studies in Asian American adults
consistently identify lack of knowledge regarding sero-
logical status, the importance of being tested, disease
transmission and prevention [16,17]. Community out-
reach programs have proven to be effective at increas-
ing HBV awareness, identifying patients with HBV
infections and offering services for linkage to care,
especially for those lacking insurance or showing low
cultural affinity to the US healthcare system [18].
The combination of high HBV prevalence and low
screening reports is a significant health concern in
California as one of the top five states with the largest
populations of Asians, 63% of which are foreign-born
[19]. The 2007–2011 American Community Survey
(ACS) estimates almost 24,000 residents in the Inland
Empire (Urban area in Southern California consisting
of Riverside County and San Bernardino County) identify
themselves as of Korean origin or descent, 19,000 identify
as 1st generation (foreign-born) Korean Americans [20].
Loma Linda University Medical Center serves the Inland
Empire and a significant number of the Asian American
residents of the area.
While there is a reasonable expectation of greater HBV
prevalence among immigrants compared to the general U.
S. population, there is no data regarding HBV prevalence
among Koreans in the Inland Empire. The common
presumption that HBsAg seroprevalence of foreign-
born U.S. residents is similar to HBV endemicity in
their country of origin is a complex premise due to the
variation in rates recently reported. The aim of this
study was to screen at least 1,000 adult Koreans in the
Inland Empire to establish HBV serological diagnoses
of infection and immunity, educate, and establish
linkage to care for vaccination and consideration of
treatment.
Methods
We established a community-screening program within
local Korean communities. Subjects were screened for
hepatitis B at Korean Churches from November 2009
through February 2010. Religious congregations were
chosen because of their known function as spiritual and
social centers, providing easy access to large numbers of
the population of interest at single sites. Advertisements
highlighting the importance of hepatitis B testing and
details were placed in Korean newspapers and newslet-
ters several weeks prior to each event to target non-
church attendees and subjects from other congregations
in the area. Flyers were also posted at churches and local
primary health clinics predominantly serving Koreans.
A bilingual Korean nurse (JK) led the events. Screening
was preceded by a brief lecture on hepatitis B. Educational
materials on hepatitis B were distributed to all attendees.
Subjects completed a brief self-administered questionnaire
and provided contact information for result notification.
The questionnaire included variables such as age, gender,
providence of origin, occupation, alcohol use, and prior
hepatitis B testing and vaccination history. The questions
were limited in scope so as not to be intrusive, time
consuming, or culturally insensitive. Participants were
encouraged to fill the questionnaires but its complete-
ness was not a pre-requisite to screening. The question-
naire and all other study documentation were made
available in English and Korean for the participants to
select based on language preference.
Blood samples were obtained by venipuncture for stand-
ard diagnostic serologies: HBsAg, antiHBs, and anti-HBc
(AMA Laboratory, Monrovia, CA, USA). Test results were
used to place patients in serological profiles: 1) Infected
(HBsAg positive, antiHBs negative, anti-HBc positive),
Immune due to natural infection (HBsAg negative, antiHBs
positive, anti-HBc positive), Susceptible (HBsAg negative,
antiHBs negative, anti-HBc negative), Immune due to
vaccination (HBsAg negative, antiHBs positive, anti-HBc
negative), and Other/further testing required (HBsAg
negative, antiHBs negative, anti-HBc positive). The pro-
cessing laboratory was instructed to retain blood for all
individuals to subsequently reflex HBsAg positive sam-
ples to Anti-HBe, HBeAg and HBV DNA quantitative
PCR (Roche COBAS® TaqMan. LOQ 29 IU/ml) tests.
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A letter describing test results and their interpret-
ation (MM), along medical recommendations (MM)
was mailed to each participant. Patients with HBsAg
positive results also received result phone notification
and initial counseling by the study nurse (JK). A special
low-cost clinic was established for subjects without access
to healthcare with a discounted total fee of $326.46 for
hepatology consultation, additional laboratory tests (CBC,
PT/INR/CMP, AFP), and liver ultrasound. Similarly, a
special low-cost HBV vaccination clinic was created for
those subjects unexposed to HBV, $108 for vaccine and
booster. Results were reported to the population at large
via an advertisement and report in the area’s largest
circulation Korean newspaper. All cases were reported
to the US Department of Health & Human Services. All
participants provided written informed consent and the
study was performed according to the World Medical
Association Declaration of Helsinki. All study activities
were approved by the Institutional Review Board at Loma
Linda University (OSR#59204).
Analysis of the data was performed with statistics
package SPSS v21.0 (SPSS Inc., Chicago, Ill., USA). Para-
metric data is expressed as mean (±SD), non-parametric
is noted as median and range. Frequency is given as (N).
Tests of significance report p-values. One Sample t-test
was used to calculate prevalence and confidence inter-
vals (95% CI). Two Sample t-test was used to examine
differences in age between male and female subjects.
Chi-square (X2) test was used to test if significant vari-
ables were different across groups.
Results
Subject accrual and demographics
We conducted 10 screening events across 9 Korean
churches of varying denominations in the Inland Empire
during the screening period (3.6 months). A total of
1,007 subjects were screened for HBV. Most (973)
reported being born in Korea and had residence con-
centrated in 3 counties: San Bernardino (51.4%), LA
(23.2%), Riverside (21.8%). We report on this first gen-
eration Korean American group.
The median age among subjects was 52.3y (18-93y),
and 60.5% (589) were females. Age distributions accord-
ing to gender (Figure 1, Table 1) were not significantly
different (p = 0.128). More than half (62.2%) of partici-
pants were from the Seoul metropolitan area and 78.0%
reported having immigrated to the U.S. before the year
2000. Regardless of long-term residence in this country,
97.1% of participants preferred Korean as the language
for communication during screening and for result noti-
fication. Most participants reported greater than high
school education (75%), while only 6% reported less than
high school education (Table 2). A large number of par-
ticipants declined to disclose their occupation (356), and
of those who did, 47.2% (291) declared unemployment
or limited income (student, homemaker, retired).
Almost all subjects (95.5%) denied either recent alco-
hol consumption (701) or declared only occasional use
(229). Most participants denied knowledge of personal
(82.3%) or family (76.8%) history of liver disease, and de-
nied being previously tested for viral hepatitis (61.5%).
Across the entire study sample, 24.7% (240) declared
they had been vaccinated against HBV.
Serological diagnoses
The prevalence of hepatitis B infection was 3.0% (1.9-
4.0%). Immunity due to natural infection was seen in
35.7% (32.6-38.7%) of participants. Susceptible individ-
uals constituted 20.1% (17.6-22.7%) of participants,
while 40.3% (37.2-43.4%) had immunity due to vaccin-
ation. A small number of 0.9% (0.3-1.5%) of subjects were
exposed but required further testing due to multiple
Figure 1 Overall study sample age distribution and gender stratification among 973 first generation Korean adults screened for
Hepatitis B in the Inland Empire during 2009–2010.
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interpretations of the results. Among the 29 infected sub-
jects the median DNA quantitative PCR was 285 IU/ml
(29 to ≥ 110,000,000 IU/ml): < 2,000 IU/ml in 17, 2000–
20,000 IU/ml in 3, and >20,000 IU/ml in 8.
Serological and demographic correlations
HBV prevalence was higher in males compared to females
(4.9% vs. 1.7%, p = 0.004). The median age among those
infected was 50 y (26-63y) with 23 of the 29 cases concen-
trated in the 40–69 age range and only 2 infected partici-
pants under 30 years old (Table 1). The majority (27) of
those infected denied consuming alcohol (17) or declared
only occasional use (10). The HBsAg positive group also
denied knowledge of personal (72.4%) or family (58.6%)
history of liver disease. Despite these reports, there was a
higher proportion of HBsAg positive participants among
subjects with a family history of liver disease compared to
those without (6.3% vs. 2.3%, p = 0.023).
Almost half (13) of those infected stated this was the
first time they had been tested for hepatitis B, and 5 re-
ported having received vaccination. Most of the infected
participants (20) were HBeAg negative with median
DNA quantitative PCR of 164 IU/ml (29–18,019 IU/ml),
while 8 cases were HBeAg positive with median DNA
quantitative PCR of ≥ 110,000,000 IU/ml (36,040 to ≥
110,000,000 IU/ml). Further testing was not performed
for one of the HBsAg positive subjects due to low sam-
ple volume.
Of the 29 infected participants only 1 had health
insurance. Despite this barrier, 2 of the 10 infected
women and 6 of the 19 men had effective follow-up
visits, for a total of 27.5% (8) success in linkage to care.
On average, 78 days passed between result notification
and appointment in our hepatology clinic for evalu-
ation with further testing and ultrasound. Of the 8
participants seen in clinic half did not require treat-
ment. The other half was provided guidance on patient
medication assistance programs and started antiretro-
viral therapy.
The vaccination rate was higher in women as com-
pared to men (44.0% vs. 34.6%, p. =0.004). The vaccin-
ation rate was significantly different across self-reported
education levels (p < 0.001) (Table 2). The vaccination
rate was 43.0% in those declaring “More than high
school” education, 34.0% in those that graduated high
school, and only 17.2% in those who had not.
Table 1 Observed frequencies of HBsAg positive diagnosis stratified by age and gender among 973 first generation
Korean adults screened for hepatitis B in the Inland Empire during 2009-2010
Male Female
Age (y) HBsAg (+) Sample population Age specific prevalence (%) HBsAg (+) Sample population Age specific prevalence (%)
0-9 0 0 0.0 0 0 0.0
10-19 0 7 0.0 0 4 0.0
20-29 2 18 11.0 0 30 0.0
30-39 2 47 4.0 2 73 3.0
40-49 3 80 4.0 5 145 3.0
50-59 8 107 7.0 2 189 1.0
60-69 4 96 4.0 1 116 1.0
70-79 0 24 0.0 0 26 0.0
80-89 0 4 0.0 0 5 0.0
90-99 0 1 0.0 0 1 0.0
100+ 0 0 0.0 0 0 0.0
Total 19 384 4.9 10 589 1.7
Table 2 Observed frequencies for serological diagnoses stratified by education level among 973 first generation
Korean adults screened for hepatitis B in the Inland Empire during 2009–2010
Education level Infected Immune due to
natural infection





Declined to answer 0 13 (3.7%) 5 (2.6%) 17 (4.3%) 0 35 (3.6%)
Less than High School 1 (3.5%) 35 (10.1%) 10 (5.1%) 10 (2.6%) 2 (22.2%) 58 (6.0%)
High school 5 (17.2%) 59 (17.0%) 31 (15.8%) 51 (13.0%) 4 (44.4%) 150 (15.4%)
More than High School 23 (79.3%) 240 (69.2%) 150 (76.5%) 314 (80.1%) 3 (33.3%) 730 (75.0%)
Total 29 (100%) 347 (100%) 196 (100%) 392 (100%) 9 (100%) 973 (100%)
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There was a statistically significant (p < 0.001) discrep-
ancy between immunity due to vaccination based on
serological results and self-declared vaccination history
across all participants (Table 3). Of the 240 subjects
thought to have been previously vaccinated, there was a
significant (p < 0.001) disparity with serological markers:
60.4% (145) had serological evidence of immunity by
vaccine, 26.3% (63) had immunity due to natural infec-
tion, 10.8% (26) were susceptible, and 2.1% (5) were in-
fected. 41.8% (199) of subjects reporting not being
vaccinated (476) had in fact serological evidence of im-
munity by vaccine. The overall rate of incorrect report
of immunization status was 35.1% (342), differing
across education levels (p = 0.008) but not between
genders (p = 0.888). Most (74.3%) of susceptible indi-
viduals requiring vaccination or follow up for add-
itional tests did not have medical insurance. Only 1
participant followed the recommendation for vaccin-
ation and 1 for further testing.
Discussion
This study examined the prevalence hepatitis B sero-
logical diagnoses in first generation adult Koreans at-
tending houses of worship in the Southern California
Inland Empire. When compared with the most recent
ACS data [21] on East Asian residents in San Bernardino
and Riverside, our study sample was similar in mean
age, proportion immigrating before 2000, education
level, male to female ratio, and preference for using their
native language. Consequently the prevalence found in
this study is believed to be an accurate estimate to that
of the first generation Koreans residing in the Inland
Empire.
The 3.0% HBV prevalence is lower than the ≥8% en-
demic rate described by the CDC but closer to current
reports of 3.7% out of Korea [8]. A recent study [22]
examining a similar but mixed Korean and Chinese
population in Southern California also found a lower
than expected HBV prevalence of 3.9% among Koreans
and discrepancies between reported vaccination and
immunity by serological evidence. Our data is also
comparable to this study in terms of demographics
such as age, gender ratio, and proportion of foreign-
born individuals. Our cohort is however perhaps more
homogeneous, recruited solely by a “grass-roots” ap-
proach within attendees at religious congregations,
without direct recruitment of subjects in or to medical
facilities. Recent data from the California Health Inter-
view Survey show that Korean Americans have the
highest uninsured rate among Asian Americans in
California [23]. With as many as 70% of Koreans in the
U.S. attending religious services regularly, most being
first generation immigrants [24], we believe that reli-
gious congregations are therefore optimal locations for
health screenings of this type.
The HBV prevalence was higher for men than for
women, congruent with previous studies showing gender
difference in seroconversion and HBsAb production
after infection [22,25-27]. Both the prevalence of HBsAg
and age distribution of the study sample were con-
centrated in the 40–59 year age group. As expected, sub-
jects <20 years old had the lowest HBV prevalence.
Subjects born after the introduction of the universal
vaccination reflect the impact of these programs. How-
ever this age group (11) was not well represented in
our sample. South Korea’s population proportion of
this age bracket is much higher than in our sample
(33.5% vs. 1.1%).
Analysis of our data leads us to believe that Korean
province of origin and reported education level play a
greater role in the observed prevalence in this study.
Two thirds of all participants stated migrating from the
capital city of Seoul, the country’s biggest urban and in-
dustrial center [28]. Areas of urban development such as
Seoul see not only the highest proportions of tertiary
education but are often the epicenter of national policies
such as vaccination programs [29]. The education level
for most study participants of studies beyond high
school (75%) was comparable to that of Seoul (69%) and
higher than the reported average secondary level of
education for adults in all South Korea [30]. As previ-
ously reported, both education level and access to care
in metropolitan households are strongly associated
with decreased prevalence, increase vaccination rates
and awareness of hepatitis B [31,32]. The authors
recognize some questions were not perceived as suit-
able for the public setting due to social stigma, as
reflected in the reluctance to answer items in our
Table 3 Observed frequencies for serological diagnoses stratified by declared HBV vaccination status among 973 first
generation Korean adults screened for hepatitis B in the Inland Empire during 2009–2010
Declared
vaccination







Yes 5 (17.2%) 63 (18.2%) 26 (13.3%) 145 (37.0%) 1 (11.1%) 240 (24.7%)
No 16 (55.2%) 199 (57.3%) 127 (64.8%) 127 (32.4%) 7 (77.8%) 476 (48.9%)
Do not know 8 (27.6%) 85 (24.5%) 43 (21.9%) 120 (30.6%) 1 (11.1%) 257 (26.4%)
Total 29 (100%) 347 (100%) 196 (100%) 392 (100%) 9 (100%) 973 (100%)
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questionnaire pertaining to sensitive information. Con-
sequently, it is difficult to associate our findings to
other factors.
Nonetheless, the lower HBV prevalence points to a
closer examination of CDC and WHO travel guidelines
[5]. New epidemiological data can serve to reclassify
South Korea to intermediate hepatitis B prevalence level,
reflecting successful universal HBV vaccination pro-
grams that have had a documented impact on the hepa-
titis B infection decline in China, Taiwan and South
Korea [9-11]. The reported 0.2% HBV prevalence for
those < 18 years [33] in South Korea is comparable to
that of the U.S. general population. On the other hand
HBV prevalence remains as high as 6.2% for adults aged
50–60 years old in Asia [7], suggesting that age-based
cohort screening for immigrants is recommended.
Subjects in this study had significant discrepancies be-
tween vaccination based on serological results and self-
declared vaccination history. These results highlight the
importance of complete serological screening among im-
migrants before recommending immunization, as well as
serological follow up to confirm successful immunization.
A recently issued IOM action plan for Hepatitis B pre-
vention and management [34] is consistent with cost-
effectiveness studies favoring the ‘Screen and Treat’ model
[35-37] and the incorrect report of immunization status
findings in this cross sectional prevalence study. Further-
more, our results illustrate providers and policy makers
should consider the new prevalence estimates when pro-
viding services for foreign-born patients.
Hepatitis B screening should be approached consider-
ing the prevalence linked to patient’s country of origin.
However, there is great need for revision of historically
reported rates across the world in order to assess a more
accurate infection risk among immigrants. Barriers such
as poor HBV knowledge, low socioeconomic and educa-
tional background are associated with low rates of self-
initiated screening across immigrants from nations with
>2.0% HBV prevalence [28]. These factors should lead
to targeted screening. Considering the growing number
of Asian immigrants, California faces an especially com-
plex challenge among its foreign-born residents due to
language barrier, lack of access or understanding the
healthcare system, cultural beliefs, denial or unaware-
ness of increased risk, social stigma, concern about cost
and results.
Conclusion
The hepatitis B infection prevalence among first generation
Korean immigrants in the Inland Empire may be lower
than expected based on previous reports from the CDC
and WHO. Self-report of hepatitis B immunization status
is often inaccurate and can lead to additional costs,
unnecessary vaccination, and dangerous perception of
prevention among contagious carriers. Despite the
lower than expected HBV prevalence, an infection rate
>2% indicates that this population is still at risk and
should be screened. Complete serological testing can
lead to optimal management of those individuals at
risk for hepatitis B.
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